The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus - PubMed (original) (raw)
The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus
J E Strong et al. EMBO J. 1998.
Abstract
NIH-3T3 cells, which are resistant to reovirus infection, became susceptible when transformed with activated Sos or Ras. Restriction of reovirus proliferation in untransformed NIH-3T3 cells was not at the level of viral gene transcription, but rather at the level of viral protein synthesis. An analysis of cell lysates revealed that a 65 kDa protein was phosphorylated in untransformed NIH-3T3 cells, but only after infection with reovirus. This protein was not phosphorylated in infected or uninfected transformed cells. The 65 kDa protein was determined to be the double-stranded RNA-activated protein kinase (PKR), whose phosphorylation leads to translation inhibition. Inhibition of PKR phosphorylation by 2-aminopurine, or deletion of the Pkr gene, led to drastic enhancement of reovirus protein synthesis in untransformed cells. The emerging picture is one in which early viral transcripts trigger PKR phosphorylation in untransformed cells, which in turn leads to inhibition of translation of viral genes; this phosphorylation event is blocked by an element(s) in the Ras pathway in the transformed cells, allowing viral protein synthesis to ensue. The usurpation of the Ras signaling pathway therefore constitutes the basis of reovirus oncolysis.
Similar articles
- Unshackling the links between reovirus oncolysis, Ras signaling, translational control and cancer.
Shmulevitz M, Marcato P, Lee PW. Shmulevitz M, et al. Oncogene. 2005 Nov 21;24(52):7720-8. doi: 10.1038/sj.onc.1209041. Oncogene. 2005. PMID: 16299532 Review. - Expression of HBX, an oncoprotein of hepatitis B virus, blocks reoviral oncolysis of hepatocellular carcinoma cells.
Park EH, Koh SS, Srisuttee R, Cho IR, Min HJ, Jhun BH, Lee YS, Jang KL, Kim CH, Johnston RN, Chung YH. Park EH, et al. Cancer Gene Ther. 2009 May;16(5):453-61. doi: 10.1038/cgt.2008.95. Epub 2008 Dec 19. Cancer Gene Ther. 2009. PMID: 19096445 - CUG2, a novel oncogene confers reoviral replication through Ras and p38 signaling pathway.
Park EH, Park EH, Cho IR, Srisuttee R, Min HJ, Oh MJ, Jeong YJ, Jhun BH, Johnston RN, Lee S, Koh SS, Chung YH. Park EH, et al. Cancer Gene Ther. 2010 May;17(5):307-14. doi: 10.1038/cgt.2009.83. Epub 2010 Jan 15. Cancer Gene Ther. 2010. PMID: 20075984 - Double-stranded RNA-dependent protein kinase (PKR) is regulated by reovirus structural proteins.
Yue Z, Shatkin AJ. Yue Z, et al. Virology. 1997 Aug 4;234(2):364-71. doi: 10.1006/viro.1997.8664. Virology. 1997. PMID: 9268168 - Connecting reovirus oncolysis and Ras signaling.
Marcato P, Shmulevitz M, Lee PW. Marcato P, et al. Cell Cycle. 2005 Apr;4(4):556-9. doi: 10.4161/cc.4.4.1600. Epub 2005 Apr 10. Cell Cycle. 2005. PMID: 15753655 Review.
Cited by
- Oncolytic virotherapy against lung cancer: key receptors and signaling pathways of viral entry.
Dong W, Luo Y, He D, Zhang M, Zeng J, Chen Y. Dong W, et al. Front Immunol. 2024 Oct 4;15:1473288. doi: 10.3389/fimmu.2024.1473288. eCollection 2024. Front Immunol. 2024. PMID: 39430750 Free PMC article. Review. - Oncolytic viruses in the treatment of cancer: a review of current strategies.
Zeyaullah M, Patro M, Ahmad I, Ibraheem K, Sultan P, Nehal M, Ali A. Zeyaullah M, et al. Pathol Oncol Res. 2012 Oct;18(4):771-81. doi: 10.1007/s12253-012-9548-2. Epub 2012 Jun 20. Pathol Oncol Res. 2012. PMID: 22714538 Review. - Reovirus receptors, cell entry, and proapoptotic signaling.
Danthi P, Holm GH, Stehle T, Dermody TS. Danthi P, et al. Adv Exp Med Biol. 2013;790:42-71. doi: 10.1007/978-1-4614-7651-1_3. Adv Exp Med Biol. 2013. PMID: 23884585 Free PMC article. Review. - The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers.
Eissa IR, Bustos-Villalobos I, Ichinose T, Matsumura S, Naoe Y, Miyajima N, Morimoto D, Mukoyama N, Zhiwen W, Tanaka M, Hasegawa H, Sumigama S, Aleksic B, Kodera Y, Kasuya H. Eissa IR, et al. Cancers (Basel). 2018 Sep 26;10(10):356. doi: 10.3390/cancers10100356. Cancers (Basel). 2018. PMID: 30261620 Free PMC article. Review. - REO-10: a phase I study of intravenous reovirus and docetaxel in patients with advanced cancer.
Comins C, Spicer J, Protheroe A, Roulstone V, Twigger K, White CM, Vile R, Melcher A, Coffey MC, Mettinger KL, Nuovo G, Cohn DE, Phelps M, Harrington KJ, Pandha HS. Comins C, et al. Clin Cancer Res. 2010 Nov 15;16(22):5564-72. doi: 10.1158/1078-0432.CCR-10-1233. Epub 2010 Oct 6. Clin Cancer Res. 2010. PMID: 20926400 Free PMC article. Clinical Trial.
References
- J Virol. 1993 Mar;67(3):1688-92 - PubMed
- J Biol Chem. 1995 Sep 8;270(36):20883-6 - PubMed
- Virology. 1993 Jun;194(2):537-47 - PubMed
- Virology. 1993 Nov;197(1):405-11 - PubMed
- Virology. 1993 Nov;197(1):412-4 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources